Institutional investors purchased a net $9.0 million shares of TXMD during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 62.02% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 3.0 Million shares of TherapeuticsMD Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.3 Million shares of TherapeuticsMD Inc
WELLINGTON MANAGEMENT CO. LLP Bought 1.5 Million shares of TherapeuticsMD Inc